Latest round: Growth. Erik Holmlin is the CEO of Bionano Genomics, a genome analysis company specializing in tools and services for genetic research.
Erik Holmlin is the CEO of Bionano Genomics, a genome analysis company specializing in tools and services for genetic research and patient testing using its Saphyr system. He also manages the company's diagnostic testing business, Lineagen, which focuses on conditions like autism spectrum disorder and other neurodevelopmental disabilities.
Full founder directory · Investor directory · Company funding database · Fundraising library